The transcription factor SP3 drives TNF-α expression in response to Smac mimetics
The transcription factor SP3 drives TNF-α expression in response to Smac mimetics
复制标题
DOI:
10.1126/scisignal.aat9563
复制
发表时间:
2019-01-29
影响因子:
7.3
通讯作者:
Korneluk, Robert G.
中科院分区:
文献类型:
--
作者:
Beug, Shawn T.;Cheung, Herman H.;Korneluk, Robert G.
The controlled production and downstream signaling of the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) are important for immunity and its anticancer effects. Although chronic stimulation with TNF-alpha is detrimental to the health of the host in several autoimmune and inflammatory disorders, TNF-alpha -contrary to what its name impliesleads to cancer formation by promoting cell proliferation and survival. Smac mimetic compounds (SMCs), small-molecule antagonists of inhibitor of apoptosis proteins (IAPs), switch the TNF-alpha signal from promoting survival to promoting death in cancer cells. Using a genome-wide siRNA screen to identify factors required for SMC-toTNF-alpha-mediated cancer cell death, we identified the transcription factor SP3 as a critical molecule in both basal and SMC-induced production of TNF-alpha by engaging the nuclear factor-kappa B (NF-kappa B) transcriptional pathway. Moreover, the promotion of TNF-alpha expression by SP3 activity confers differential sensitivity of cancer versus normal cells to SMC treatment. The key role of SP3 in TNF-alpha production and signaling will help us further understand TNF-alpha biology and provide insight into mechanisms relevant to cancer and inflammatory disease.